[1]
M. Camargo, M. I. Soto Marín, O. Zea, and D. Saavedra, “Imatinib treatment and pharmacogenotype CYP3A4 in relation with the clonal expansion Ph(+) in chronic myeloid leukemia (CML)”., Colomb Med, vol. 39, no. 4, pp. 314–322, Dec. 2008.